All Stories

  1. The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation

    Article • Therapeutics and Clinical Risk Management, March 2017, Dove Medical Press

    Christian Gleißner

  2. Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia

    Article • Innate Immunity, February 2016, SAGE Publications

    Christian Gleißner

  3. Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation

    Article • Drug Design Development and Therapy, February 2016, Dove Medical Press

    Christian Gleißner

  4. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

    Article • Drug Design Development and Therapy, February 2015, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  5. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy

    Article • Drug Design Development and Therapy, December 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  6. CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

    Article • Drug Design Development and Therapy, November 2014, Taylor & Francis

    Dr Mohammadreza Akhavanpoor, Christian Gleißner, Hugo Katus

  7. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

    Article • Drug Design Development and Therapy, September 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  8. Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta‐analysis

    Article • British Journal of Clinical Pharmacology, June 2014, Wiley

    Christian Gleißner

  9. A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

    Article • Journal of Visualized Experiments, May 2014, MyJove Corporation

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  10. Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

    Article • Drug Design Development and Therapy, May 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  11. Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2014, Wolters Kluwer Health

    Christian Gleißner

  12. CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+in vitro and in vivo

    Article • Innate Immunity, March 2014, SAGE Publications

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  13. Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

    Article • Drug Design Development and Therapy, November 2013, Taylor & Francis

    Christian Gleißner

  14. An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

    Article • Journal of Visualized Experiments, June 2013, MyJove Corporation

    Christian Gleißner

  15. High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival

    Article • Transplant International, December 2012, Frontiers

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  16. Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

    Article • Drug Design Development and Therapy, October 2012, Taylor & Francis

    Christian Gleißner, Hugo Katus

  17. Platelet-Derived Chemokines in Atherogenesis: What’s New?

    Article • Current Vascular Pharmacology, July 2012, Bentham Science Publishers

    Christian Gleißner

  18. Subclinical Atherosclerosis and Chronic Troponin Elevation: The Voice of Silence in Diabetics

    Article • Journal of the American College of Cardiology, July 2012, Elsevier

    Christian Gleißner

  19. Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis

    Article • Frontiers in Physiology, January 2012, Frontiers

    Christian Gleißner

  20. PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

    Article • European Journal of Medical Research, January 2011, Springer Science + Business Media

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  21. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability

    Article • Basic Research in Cardiology, December 2010, Springer Science + Business Media

    Christian Gleißner

  22. CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages

    Article • The Journal of Immunology, March 2010, The American Association of Immunologists

    Christian Gleißner

  23. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation

    Article • Blood, January 2010, American Society of Hematology

    Christian Gleißner

  24. CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages

    Article • Circulation Research, January 2010, Wolters Kluwer Health

    Christian Gleißner

  25. Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications

    Article • Human Immunology, May 2009, Elsevier

    Christian Gleißner

  26. Platelet Chemokines in Vascular Disease

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 2008, Wolters Kluwer Health

    Christian Gleißner

  27. Ezetimibe effectively lowers LDL‐cholesterol in cardiac allograft recipients on stable statin therapy

    Article • Clinical Transplantation, September 2008, Wiley

    Christian Gleißner

  28. Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2008, Wolters Kluwer Health

    Christian Gleißner

  29. CXCL4 in atherosclerosis: Possible roles in monocyte arrest and macrophage foam cell formation

    Article • Thrombosis and Haemostasis, October 2007, Schattauer GmbH

    Christian Gleißner

  30. Mechanisms by which diabetes increases cardiovascular disease

    Article • Drug Discovery Today Disease Mechanisms, September 2007, Elsevier

    Christian Gleißner

  31. 372: IL-10 inhibits endothelium-dependent T-cell costimulation by upregulation of ILT3/4 in human vascular endothelial cells

    Article • The Journal of Heart and Lung Transplantation, February 2007, Elsevier

    Christian Gleißner

  32. IL‐10 inhibits endothelium‐dependent T cell costimulation by up‐regulation of ILT3/4 in human vascular endothelial cells

    Article • European Journal of Immunology, December 2006, Wiley

    Christian Gleißner

  33. Role of erythropoietin in anemia after heart transplantation

    Article • International Journal of Cardiology, October 2006, Elsevier

    Christian Gleißner

  34. Impact of Pre-Operative Diabetes Mellitus Upon Early and Late Survival After Heart Transplantation: A Possible Era Effect

    Article • The Journal of Heart and Lung Transplantation, September 2005, Elsevier

    Christian Gleißner

  35. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cellsin vitro

    Article • European Journal of Immunology, June 2005, Wiley

    Christian Gleißner

  36. Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation*

    Article • Transplant International, February 2005, Frontiers

    Christian Gleißner

  37. Interleukin-10 reduces endothelium-dependent T cell costimulation through upregulation of suppressor of cytokine signaling-3 and immunoglobulin-like transcript 3 and 4

    Article • The Journal of Heart and Lung Transplantation, February 2005, Elsevier

    Christian Gleißner

  38. Inflammatory and pro-thrombotic protein expression is induced in human vascular endothelial cells by lymphocyte-associated LIGHT

    Article • The Journal of Heart and Lung Transplantation, February 2005, Elsevier

    Christian Gleißner

  39. Erythropoietin treatment of anemia post heart transplantation raises hemoglobin levels and improves quality of life

    Article • The Journal of Heart and Lung Transplantation, February 2005, Elsevier

    Christian Gleißner

  40. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function1

    Article • Transplantation, March 2004, Wolters Kluwer Health

    Christian Gleißner

  41. Pre-operative diabetes is associated with reduced survival in the early and chronic phase after heart transplantation

    Article • The Journal of Heart and Lung Transplantation, February 2004, Elsevier

    Christian Gleißner

  42. Increased gene expression of inflammatory cytokines and endotoxin receptors in peripheral blood mononuclear cells of patients with chronic heart failure

    Article • The Journal of Heart and Lung Transplantation, February 2004, Elsevier

    Christian Gleißner

  43. Human endothelial T cell costimulation is inhibited by interleukin 10 (IL-10) through induction of suppressor of cytokine secretion-3 (SOCS-3) and ILT-3

    Article • The Journal of Heart and Lung Transplantation, February 2004, Elsevier

    Christian Gleißner

  44. Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation

    Article • The Journal of Heart and Lung Transplantation, February 2004, Elsevier

    Christian Gleißner

  45. Acute cellular rejection after human heart transplantation is associated with ICOS+ graft-infiltrating T lymphocytes and increased endothelial expression of inducible costimulator ligand (ICOSL)

    Article • The Journal of Heart and Lung Transplantation, February 2004, Elsevier

    Christian Gleißner

  46. Diagnostic efficiency of rejection monitoring after heart transplantation with cardiac troponin T is improved in specific patient subgroups

    Article • Clinical Transplantation, May 2003, Wiley

    Christian Gleißner

  47. IL-10 induces suppressor of cytokine secretion-3 (SOCS-3) and ILT-3 in human endothelial cells and inhibits T cell costimulation

    Article • The Journal of Heart and Lung Transplantation, January 2003, Elsevier

    Christian Gleißner

  48. Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantation

    Article • Transplantation Proceedings, September 2002, Elsevier

    Christian Gleißner